IL2 and acute lymphoblastic leukemia: At present, the application of maintenance therapy after ASCT is mainly given to patients with ALL, and maintenance therapy at IH for ALL after ASCT usually includes maintenance chemotherapy and immunotherapy (including interleukin‐2 [IL‐2] and interferon‐α).26, 29, 48, 49, 50, 51, 52